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Abstract
Background: Acinetobacter baumannii is emerging as an important nosocomial pathogen. Multidrug
resistance, as well as ability to withstand environmental stresses, makes eradication of A. baumannii
difficult, particularly from hospital settings.
Results: Over a six-year period, 73 isolates of A. baumannii were collected from infected patients
in two hospitals in Italy. While 69 out of the 73 isolates displayed identical multidrug antibiotic
resistance pattern, they were susceptible to carbapenems. Genetic profiles of these 69 isolates,
determined by Pulsed Field Gel Electrophoresis (PFGE), indicated that they were genetically related
and could be clustered in a specific clone, called SMAL. We tested the ability of the SMAL clone to
form biofilm, an important determinant for bacterial colonization of the human host and for
persistence in the hospital environment. Biofilm formation by A. baumannii SMAL, measured as
surface adhesion to polystyrene, is strongly affected by growth conditions, being impaired in rich
growth media such as LB, while being favoured in glucose-based medium. Surface adhesion in
glucose-based media is inhibited by treatment with cellulase, suggesting that it depends on
production of cellulose or of a chemically related extracellular polysaccharide. Exposure of A.
baumannii SMAL to subinhibitory concentrations of imipenem resulted in biofilm stimulation and
increased production of iron uptake proteins. Growth in iron-supplemented medium also
stimulated surface adhesion, thus suggesting that increased intracellular iron concentrations might
act as an environmental signal for biofilm formation in A. baumannii SMAL.
Conclusions: Our results indicate that exposure to subinhibitory concentrations of imipenem can
stimulate biofilm formation and induce iron uptake in a pathogenic strain of A. baumannii, with
potential implications on antibiotic susceptibility and ability to persist in the human host.
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Bacteria belonging to the genus Acinetobacter, in particular
Acinetobacter baumannii and the closely related Acineto-
bacter 13 TU and gen.sp. 3 (referred to as Acinetobacter bau-
mannii sensu lato), are important opportunistic pathogens
in hospital-acquired infections (reviewed in [1]).
A. baumannii can cause pneumonia, wound infections,
urinary tract infections, bacteremia, and meningitis [2,3].
The hospital environment can represent an important res-
ervoir for A. baumannii during nosocomial infections; in
particular, patients in long-term care facilities can be col-
onized by A. baumannii and carry the bacterium for long
periods with no visible symptoms [1]. Ability to persist in
the hospital environment is related to multidrug resist-
ance [1,4], which allows A. baumannii to survive pro-
longed antimicrobial therapy in hospitalized patients.
Multidrug resistance in A. baumannii clinical isolates is
mediated by a variety of mechanisms, such as modifica-
tion of target sites, efflux pumps, enzymatic inactivation
of antibiotics, etc. (reviewed in [1]). Carbapenems (e.g.
imipenem) have been used as antibiotics of choice for
treatment of A. baumannii infections, but increasing resist-
ance to these antimicrobial agents mediated by β-lactama-
ses of the B and D classes is undermining this option [4-
8].
In addition to multidrug resistance, A. baumannii is able to
withstand environmental stresses such as exposure to
detergents [9] and desiccation [10], which can contribute
to its persistence in the hospital environment. Biofilm for-
mation is considered an important factor in resistance to
stresses and in bacterial colonization and persistence in
different environmental niches [11]. It has been reported
that ability of A. baumannii to form biofilm in laboratory
conditions correlates with resistance to complement-
mediated bacterial killing [12]. This observation suggests
that biofilm formation can contribute to A. baumannii sur-
vival during host infection, thus representing an impor-
tant virulence factor. In contrast, studies addressing
possible correlation between biofilm and multidrug
resistance have produced conflicting results [13-16]. Abil-
ity to form biofilm has been reported for numerous A.
baumannii strains [12-16], and several biofilm determi-
nants, i.e., the csu pili [17], and the outer membrane-asso-
ciated proteins Bap [18] and OmpA [19] have been
identified.
In this report, we have characterized A. baumannii isolates
responsible for nosocomial infections in two hospitals in
Italy. We showed that all isolates were genetically related,
suggesting that they originate from a single clone, termed
SMAL. A. baumannii SMAL is not clonally related to
known multidrug resistant A. baumannii lineages such as
European clones I and II [20,21]. We have studied how
growth conditions and exposure of A. baumannii SMAL to
subinhibitory concentrations of imipenem affects its abil-
ity to form biofilm, a cellular process with important con-
sequences on sensitivity to antimicrobial agents and on
microbial persistence in the human host.
Results
Characterization of Acinetobacter baumannii clinical 
isolates
A total of 73 Acinetobacter baumannii isolates responsible
of various infections were collected from patients in dif-
ferent wards of two Hospitals in Pavia, Italy, between
2002 and 2007. 69 out of 73 isolates showed identical
multidrug resistant phenotype, being resistant to fluoro-
quinolones, aminoglycosides, and most β-lactams; how-
ever, they retained susceptibility to carbapenems,
tetracycline and to ampicillin/sulbactam (Table 1). The
remaining 4 isolates showed different antibiotic suscepti-
bility patterns, including resistance to carbapenems and
tetracycline (data not shown). The 69 isolates were char-
acterized by an identical β-lactamase pattern, producing 3
distinct β-lactamases, with pI values of 6.1, 7.0, >8.2,
compatible with those of OXA-10, OXA-51-like and
AmpC-type enzymes. PCR experiments and direct DNA
sequencing using the same primers confirmed the pres-
ence of blaOXA-10 and blaOXA-90 genes (Table 1). The β-lacta-
mase pattern shown by the isolates is consistent with their
susceptibility to carbapenems: indeed, OXA-51-like β-
lactamases only possess slow hydrolytic activity against
imipenem and result in very little effect on imipenem sen-
sitivity even when overexpressed [22].
Genomic DNA was extracted from every A. baumannii iso-
late, digested with ApaI restriction endonuclease, and ana-
lysed by PFGE. The dendrogram clearly revealed that all
69 A. baumannii isolates showing identical multidrug
resistant phenotype displayed more than 80% similarity,
with differences in DNA patterns never exceeding 3 DNA
restriction fragments. A comparison of a selection of iso-
lates with strains RUH875 and RUH134, representative of
European clones I and II, is shown in Figure 1. Our results
indicate that, according to the criteria and the cut-off value
defined, all isolates belong to the same clone, which was
called SMAL, from the hospitals and locations where it
had caused outbreaks most frequently (S. Matteo/S.
Maugeri Hospitals Acute care and Long term care facili-
ties). PFGE experiments indicate that the great majority of
isolates belong to a main clonal SMAL subtype, showing
100% genetic similarity, while a smaller number of iso-
lates display a level of genetic relatedness with the SMAL
main clonal subtype not lower than 83.5%, defining the
clonal subtypes SMAL 1, 2, 3, and 4 (Table 1).
A. baumannii strains are notorious for causing recurrent
hospital outbreaks, and a few lineages achieve epidemicPage 2 of 14
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Table 1: nii analyzed in this study.
b
Numbe
isolat
CZ CP IP MP MIC IP 
(μg/ml)
β-
lactamases
Pulsotype
2 >32 >16 ≤1 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL
6 >32 >16 ≤1 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL
2 >16 / 2 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL
6 >16 >16 ≤1 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL, 
SMAL 2,
3 >16 >16 ≤1 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL, 
SMAL 3
3 >16 / 2 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL
8 >16 >16 ≤1 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL
8 >16 / 2 ≤1 0.5-1.0 AmpC, OXA-
90, OXA-10
SMAL, 
SMAL 1
1 >16 >16 ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 2 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
2 >16 >16 ≤1 ≤1 0.5-1 AmpC, OXA-
90, OXA-10
SMAL Antimicrobial susceptibility, production of β-lactamases, and pulsotype of the 69 isolates of A. bauman
MIC Method Phoenix (μg/ml)
r of 
es
Hospital Sample 
Source
Ward/unita TE A/S CI AK GM PP PT AT
S. Matteo Blood Medicine ≤2 8/4 >2 >32 >8 >64 >64/4 >16
S. Matteo Sputum Medicine ≤2 8/4 >2 >32 >8 >64 >64/4 >16
S. Matteo Urine Medicine 4 / >2 >32 >8 >64 >64/4 >16
S. Matteo Soft tissue 
swab
Medicine 4 8/4 >2 >32 >8 >64 >64/4 >16
S. Matteo Bronchoaspi
rate
Medicine / 8/4 >2 >32 >8 >64 >64/4 >16
S. Matteo Urine Surgery 4 / >2 >32 >8 >64 >64/4 >16
S. Matteo Wound 
swab
Surgery ≤2 8/4 >2 >32 >8 >64 >64/4 >16
S. Matteo Blood Surgery / / >2 >32 >8 >64 >64/4 >16
S. Matteo Pus Surgery ≤2 8/4 >2 >32 >8 >64 >64/4 >16
S. Matteo Sputum Surgery / 4/2 >2 >32 >8 >64 64/4 >16
S. Matteo Soft tissue 
swab
LTCU ≤2 / >2 >32 >8 >64 64/4 >16
S. Matteo Sputum LTCU / / >2 >32 >8 >64 64/4 >16
S. Matteo Blood LTCU / / >2 32 >8 >64 64/4 >16
S. Matteo Soft tissue 
swab
Dermatology ≤2 / >2 >32 >8 >64 >64/4 >16
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1 >16 >16 >16 ≤1 ≤ 1 AmpC, OXA-
90, OXA-10
SMAL
2 >16 >16 >16 4 2 2 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 / ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
2 >16 >16 >16 ≤1 ≤1 0.5 AmpC, OXA-
90, OXA-10
SMAL
2 >16 >16 / ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 16 ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >16 / ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
7 >16 >16 / ≤1 ≤1 1 AmpC, OXA-
90, OXA-10
SMAL
2 >16 >16 >16 ≤1 ≤1 0.5 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >32 / ≤1 ≤1 0.5-1 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >32 / ≤1 ≤1 0.5 AmpC, OXA-
90, OXA-10
SMAL
1 >16 >32 / ≤1 ≤1 0.5 AmpC, OXA-
90, OXA-10
SMAL
2 >16 >32 >16 ≤1 ≤1 0.5 AmpC, OXA-
90, OXA-10
SMAL
a PRU, pulmona E, tetracicline; A/S, ampicillin/sulbactam; CI, ciprofloxacin; AK, amikacin; GM, 
gentamicin; PP, ; MP, meropenem. Ditto marks indicate that the β-lactamase pattern was 
identical for all
Table 1: Antim aumannii analyzed in this study. (Continued)S. Matteo Pus Dermatology ≤2 8/4 >2 >32 >8 >64 >64/4
S. Matteo Wound 
swab
Ambulatory / / >2 >32 >8 >64 >64/4
S. Matteo Urine Ambulatory ≤2 / >2 >32 >8 >64 >64/4
S. Matteo Wound 
swab
Urology ≤2 / >2 >32 >8 >64 >64/4
S. Matteo Urine Nephrology / / >2 >32 >16 >64 >64/4
S. Matteo Blood Haematology 8 / >2 >32 >8 >64 >64/4
S. Maugeri Bronchoaspi
rate
PRU 8 / >2 >32 >8 >64 >64/4
S. Maugeri Urine NRU / / >2 >32 >8 >64 64/4
S. Maugeri Skin swab NRU / 8/4 >2 >32 >8 >64 >64/4
S. Maugeri Bronchoaspi
rate
NRU ≤2 / >2 >32 >8 >64 64/4
S. Maugeri Urine ORU ≤2 8/4 >2 >32 >8 >64 >64/4
S. Maugeri Skin swab ORU ≤2 8/4 >2 >32 >8 >64 64/4
S. Maugeri Urine FRU ≤2 8/4 >2 >32 >8 >64 >64/4
ry rehabilitation unit; NRU, neurological rehabilitation unit; ORU, oncological rehabilitation unit. b T
 piperacillin; PT, piperacillin/tazobactam; AT, aztreonam; CZ, ceftazidime; CP, cefepime; IP, imipenem
 the strains tested.
icrobial susceptibility, production of β-lactamases, and pulsotype of the 69 isolates of A. b
BMC Microbiology 2009, 9:270 http://www.biomedcentral.com/1471-2180/9/270status, reaching multiple hospitals or communities [23].
Examples include European clones I and II, widespread in
continental Europe, and clone III, which is however less
relevant in terms of clinical and epidemiological impor-
tance [20,21]. The SMAL clone seems to define a novel lin-
eage of A. baumannii, as suggested by significant
differences in antibiotic resistance pattern (e.g. sensitivity
to tetracycline) in comparison to European Clones I and
II [20,21]. Lack of genetic relatedness was further con-
firmed by PFGE experiments, which only showed 57%
relatedness between the SMAL clone and isolates belong-
ing to European Clones I and II (Figure 1). Multiplex PCR
performed using ompA, csuE, and blaOXA-51-like as target
genes [24] confirmed these differences (data not shown).
Biofilm formation by A. baumannii clinical isolates
The A. baumannii isolates belonging to the SMAL clone
were tested for their ability to form biofilm, measured as
surface adhesion to polystyrene microtiter plates. Biofilm
growth is considered an important factor for host coloni-
zation [25,26] and for resistance to environmental and
cellular stresses [11]. Ability to form biofilm, measured as
surface adhesion to polystyrene microtiter plates, was very
similar for all A. baumannii isolates tested (data not
shown); results shown throughout the paper refer to the
A. baumannii isolate described in Line 22 of Table 1. This
isolate was considered representative of the A. baumannii
SMAL clone since it belongs to the main genotypic sub-
group of the SMAL clone (Figure 1) and since it was the
first A. baumannii to be isolated in this survey. Surface
adhesion to microtiter plates by A. baumannii SMAL clone
was determined in various growth conditions, comparing
two growth temperatures (30°C vs. 37°C), and different
growth media: the rich peptone-based LB medium, LB
medium diluted 1:4 (LB1/4), the M9Glu/sup medium
[[27], described in Methods], and the M9Suc/sup in
which 0.2% sucrose was added as main carbon source
instead of glucose. LB1/4 was tested since it was shown to
promote production of adhesion factors in other Gram
negative bacteria, such as Escherichia coli [28]. We found
that biofilm formation by A. baumannii SMAL was
strongly affected both by growth media and by tempera-
ture: indeed, while surface adhesion was very poor in LB
medium at either 30°C or 37°C, it was clearly stimulated
by growth in LB1/4, although only at 30°C. Finally,
growth in M9Glu/sup resulted in efficient surface adhe-
sion both at 30°C and at 37°C, while growth in sucrose-
based medium (M9Suc/sup) resulted in much lower lev-
els (Figure 2A). The observation that growth temperature
affects biofilm formation in the LB1/4, but not in sugar-
based media such as M9Glu/sup, would suggest that this
process could be mediated by different mechanisms and
by different adhesion factors.
A major adhesion factor characterized in A. baumannii is
represented by the csu pili described in the A. baumannii
strain ATCC 19606 [17]. Thus, we measured by Real Time
PCR relative expression of the csuC and csuE genes in dif-
ferent growth media. The csuC and csuE genes encode
respectively a chaperone involved in pili assembly and the
pilus major subunit. Expression of csu genes was hardly
detectable in all growth conditions (data not shown).
Consistent with this result, we could not detect any pro-
duction of csu pili in A. baumannii SMAL by electron
microscopy, regardless of growth conditions (Figure 3 and
data not shown). This result would suggest that produc-
tion of csu pili, and thus their contribution to surface
adhesion, might be limited in this strain. In addition to
csu pili, A. baumannii 19606 biofilm is characterized by
efficient binding to Calcofluor [17], a fluorescent dye
which binds specifically to cellulose and chitin; this obser-
vation suggests that cellulose, which is produced as an
extracellular polysaccharide (EPS) in many bacteria [29-
32], might be a biofilm determinant in A. baumannii. To
detect possible production of cellulose, we grew A. bau-
mannii SMAL on different solid media supplemented with
Calcofluor. Interestingly, Calcofluor binding was detected
on M9Glu/sup solid medium, but not on M9Suc/sup or in
either peptone-based media (LB or LB1/4), suggesting
that growth on glucose induces production of Calcofluor-
binding EPS in A. baumannii SMAL (Figure 2B). In order
to test the possible role of this EPS as an adhesion factor,
PFGE profiles of A. baumannii genomes after digestion with ApaI restriction nuclease (Lanes 1-7, top to bottom)Figu  1
PFGE profiles of A. baumannii genomes after diges-
tion with ApaI restriction nuclease (Lanes 1-7, top to 
bottom). 5 of the 69 isolates identified in this study and ana-
lyzed by PFGE are shown (Lanes 1-5). Lane 1, Isolate from 
urine sample (see Table 1, line 22); Lane 2: Isolate from soft 
tissue swab (Table 1, line 4); Lane 3: Isolate from blood sam-
ple (Table 1, line 8); Lane 4: Isolate from wound swab (Table 
1, line 7); Lane 5: Isolate from bronchoaspirate sample (Table 
1, Line 5). Isolates were compared to strains representative 
of European clones I (RUH875, Lane 7) and II (RUH134, Lane 
6). Strains belonging to the same clone are clustered at a 
level of 80% by PFGE with the parameters used as shown by 
the dendrogram analysis shown on the left.
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A. Surface adhesion to polystyrene microtiter plates by A. baumannii SMAL cloneFigu e 2
A. Surface adhesion to polystyrene microtiter plates by A. baumannii SMAL clone. Black bars bacterial cultures 
grown in LB medium; light grey bars LB1/4 medium; white bars M9Glu/sup; dark grey bars M9Suc/sup. B. Binding of Cal-
cofluor to A. baumannii SMAL clone grown in solid media. C. Inhibition of A. baumannii biofilm formation by 
cellulase treatment: circles, M9Glu/sup medium; diamonds, M9Suc/sup medium; squares, LB1/4 medium. The 
horizontal dotted line indicates the 50% inhibition mark. IC50's values are indicated by vertical dotted lines.
LB 1/4 M9Glu/supLB M9Suc/sup
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BMC Microbiology 2009, 9:270 http://www.biomedcentral.com/1471-2180/9/270we tested surface adhesion to polystyrene in different
growth media in the presence of the cellulose-degrading
enzyme cellulase (Figure 2C). Surface adhesion was effi-
ciently inhibited by low amounts of cellulase when A.
baumannii SMAL was grown in M9Glu/sup (50% inhibi-
tion at 0.15 Units cellulase, Figure 2C), thus suggesting
that surface adhesion is mediated by cellulose production.
In contrast, cellulase was only able to impair surface adhe-
sion at much higher concentrations when A. baumannii
SMAL was grown either in M9Suc/sup or in LB1/4 media
(50% inhibition at ca. 12 and 19 Units cellulase, respec-
tively, Figure 2C). At these amounts of cellulase, inhibi-
tory effects are likely due to non-specific effects such as
changes in surface tension or other physico-chemical
properties of the medium. Cellulase effects in LB medium
were not tested due to the very inefficient biofilm forma-
tion in this medium (Figure 2A). To further verify the pos-
sible role of cellulose-related EPS as an adhesion factor, A.
baumannii SMAL biofilm formed on microtiter plates by
cells growing in M9Glu/sup medium was resuspended in
50 mM phosphate buffer pH 6.0 by vigorous pipetting
and incubated 30 minutes either in the presence or in the
absence of 1 U cellulase prior to fixation with gluteralde-
hyde and visualization by transmission electron micros-
copy. Figure 3 shows that A. baumannii SMAL cells
recovered from the biofilm appear embedded in bundle-
like filaments (Panel 3A), which disappear upon cellulase
treatment (Panel 3B), further confirming direct involve-
ment of cellulose in cell-cell aggregation.
In addition to its role of adhesion factor, cellulose, as well
as other EPS, can protect bacterial cells from environmen-
tal stresses such as desiccation and oxidative stress
[11,29]. Thus, we tested the A. baumannii SMAL clone
grown either in M9Glu/sup or in LB1/4 for resistance to
desiccation and to challenge with H2O2. A. baumannii
SMAL displayed high levels of resistance to both stresses,
which was expected since this is a common feature for the
Acinetobacter genus [1]; growth in different media did not
significantly affect its resistance level (data not shown),
suggesting that, in A. baumannii SMAL, cellulose produc-
tion might be more related to surface adhesion than to
resistance to environmental stresses.
Exposure to subinhibitory concentrations of imipenem 
affects biofilm formation
The A. baumannii SMAL clone is sensitive to carbapenems
such as imipenem (Table 1). However, in many cases, imi-
penem treatments failed to eradicate the A. baumannii
SMAL clone from patients, often resulting in relapses. We
investigated the possibility that, although sensitive to imi-
penem in standard Minimal Inhibitory Concentration
(MIC) determination assays, the A. baumannii SMAL clone
might possess mechanisms of resistance or tolerance to
this antibiotic. Exposure to subinhibitory concentrations
of antibiotics can result in the induction of adaptive
responses and in biofilm stimulation [33], which appears
to increase tolerance to antibiotics via different molecular
mechanisms (reviewed in [34]). Thus, we tested the effect
Transmission electron microscopy images of A. baumannii SMAL biofilm-forming cellsFigure 3
Transmission electron microscopy images of A. baumannii SMAL biofilm-forming cells. Panel A: A. baumannii cells 
resuspended from biofilm 10,000× magnification. The bundle-like fibers embedding the bacterial cells are indicated by the 
arrow. Panel B: A. baumannii cells resuspended from biofilm and treated with 1 Unit cellulase for 30 minutes, 12,000× magnifi-
cation.
A BPage 7 of 14
(page number not for citation purposes)
BMC Microbiology 2009, 9:270 http://www.biomedcentral.com/1471-2180/9/270of subinhibitory concentrations of imipenem on biofilm
formation by A. baumannii SMAL: concentrations of imi-
penem ranging between 0.03 and 0.125 μg/ml, which cor-
respond respectively to 1/16 and 1/4 of the MIC of
imipenem in M9Glu/sup medium, resulted in biofilm
stimulation by up to 3-fold, both at 30°C (Figure 4) and
at 37°C (data not shown). Growth rate was not impaired
by imipenem at any of the concentrations tested. In con-
trast, treatment of A. baumannii SMAL with subinhibitory
concentrations of tetracycline did not result in any signif-
icant induction of biofilm formation (data not shown),
suggesting that biofilm induction is a specific effect of imi-
penem. Since in M9Glu/sup medium surface adhesion by
A. baumannii SMAL is mediated by cellulose production
(Figure 2C), we tested whether imipenem-induced bio-
film stimulation could be inhibited by treatment with cel-
lulase. As shown in Figure 3, although cellulase did affect
biofilm formation both in the presence and in the absence
of imipenem, the extent of biofilm stimulation induced
by the antibiotic is very similar (ca. 3-fold) regardless of
the presence of cellulase. This observation seems to sug-
gest that exposure to subinhibitory imipenem concentra-
tions induce production of a cellulase-resistant adhesion
factor. To understand if imipenem-dependent biofilm
stimulation is specific for A. baumannii SMAL, we tested
the effects of subinhibitory imipenem concentration on
biofilm formation in A. baumannii strains RUH875 and
RUH134, representative of European clones I and II. In
the absence of imipenem, both strains could form biofilm
to a similar extent as A. baumannii SMAL (data not
shown). MICs of imipenem for RUH875 and RUH134 in
M9Glu/sup medium were 0.5 and 0.25 μg/ml, again very
similar to the MIC for A. baumannii SMAL. Unlike A. bau-
mannii SMAL, however, exposure to subinhibitory con-
centrations of the antibiotic failed to stimulate surface
adhesion in these strains (data not shown).
In order to identify possible imipenem-dependent bio-
film determinants we compared the patterns of mem-
brane-associated proteins of A. baumannii SMAL grown
either in the absence or in the presence of 0.125 μg/ml
imipenem (1/4 MIC). Exposure to subinhibitory imi-
penem concentrations clearly affected the intensity of a
protein band with the apparent molecular weight of ca. 70
KDa (Figure 5). The 70 KDa bands from both the control
and the imipenem-treated samples were excised from the
gel, and the proteins were digested with trypsin and iden-
tified through MALDI-TOF analysis as previously
described [35]. The 70 KDa bands were identified as a
mixture of three polypeptides, all involved in metal
uptake: the OprC protein, a copper receptor, was found
both in control and imipenem-exposed bacterial cultures.
In contrast, two proteins involved in iron uptake, a ferri-
chrome receptor protein and a TonB-dependent
siderophore, were only found in the membrane of imi-
penem-exposed cultures (Table 2). We tested the possibil-
Surface adhesion by A. baumannii SMAL clone grown in M9Glu/sup medium at 30°C i  the presence of subi hibitory imipenem concentrationsFigur 4
Surface adhesion by A. baumannii SMAL clone grown 
in M9Glu/sup medium at 30°C in the presence of 
subinhibitory imipenem concentrations. Grey bars: 
untreated samples; black bars: samples treated with 1 Unit 
cellulase.
SDS-PAGE of membrane fractions of A. baumanni SMAL cloneFigure 5
SDS-PAGE of membrane fractions of A. baumanni 
SMAL clone: the arrows point to the 70 KDa bands show-
ing different levels of expression in cultures treated with imi-
penem. The band at ca. 40 KDa was identified by MALDI-
TOF as OmpA the major outer membrane protein in A. bau-
mannii. Molecular Weight standards are shown.Page 8 of 14
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exposure to subinhibitory imipenem concentrations
could be due to transcription activation of the corre-
sponding genes. Relative transcription levels of the ferri-
chrome receptor protein- and the TonB-dependent
siderophore-encoding genes were determined by Real
Time PCR experiments, which showed that transcription
of both genes is activated by 0.125 μg/ml imipenem (1/4
the MIC) by 3.5-fold (Table 2).
Effects of iron on biofilm formation
Our results indicate that subinhibitory imipenem concen-
trations positively affect both surface adhesion (Figure 4)
and iron uptake (Figure 5, Table 2). In most bacteria, iron
is an important environmental signal for production of
adhesion factors and biofilm formation [36,37]. Thus, it
is possible that biofilm stimulation by imipenem might
depend upon higher intracellular iron concentration
mediated by increased production of iron uptake pro-
teins. To verify this hypothesis, we tested the effects of
iron on surface adhesion by A. baumannii SMAL. Addition
to the M9Glu/sup medium of FeSO4 at concentrations
ranging between 2 and 50 μM led to a 2.5-fold stimula-
tion of surface adhesion (Figure 6). Similar to what
observed for subinhibitory imipenem concentrations,
iron-dependent biofilm stimulation takes place even in
the presence of cellulase, thus suggesting that it is not
mediated by increased production of cellulose (Figure 6).
We tested the possibility that biofilm stimulation either
by iron or by subinhibitory imipenem concentrations
could be mediated by increased expression of the pili-
encoding csu genes. However, Real Time PCR experiments
showed no significant changes either in csuC or csuE tran-
scription in response to exposure either to 0.125 μg/ml
imipenem or to 50 μM FeSO4 (data not shown).
Discussion
In this work, we have reported the isolation and character-
ization of an A. baumannii strain responsible for outbreaks
both in Acute Care and in Long-Term Care Facilities in
two Italian hospitals. A. baumannii isolates showed a dis-
tinct antibiotic resistance pattern, being resistant to most
aminoglycosides and β-lactams, but sensitive to carbapen-
ems and tetracycline (Table 1). Analysis of the isolates by
PFGE suggests that they belong to a single lineage, unre-
lated to A. baumannii European clones I and II (Figure 1).
This A. baumannii clone, named SMAL (acronym of the
hospitals and wards where it was isolated), was repeatedly
isolated over a six-year period, and was able to cause dif-
ferent kinds of infections, ranging from urinary tract infec-
tions to bacteremia (Table 1), thus showing significant
potential as pathogenic strain as well as ability to persist
in the hospital environment.
Ability to form biofilm plays an important role both in
survival within the host and in persistence of A. baumannii
Table 2: Identification of membrane proteins induced by exposure to subinhibitory imipenem concentrations.
Protein identified by 
MALDI-TOF and/or 
corresponding gene in 
A. baumannii ATCC 
17978
Expected Molecular 
Weight (KDa)
Protein function Conditions in which 
proteins are produced
Gene expression in the 
presence of imipenem 
(fold induction)
OprC (A1S_0170) 67,700 Putative outer membrane 
copper receptor
Both in control and in 
imipenem-induced cultures
N.D.
(A1S_1921) 71,742 Ferrichrome-iron receptor Imipenem-induced cultures 3.51
(A1S_1063) 73,034 TonB-dependent 
siderophore receptor
Imipenem-induced cultures 3.39
Genes encoding the identified proteins are identified with the annotation number for A. baumanni ATCC 17978 strain [52].
Surface adhesion by A. baumannii SMAL clone grown in M9Glu/sup medium at 30°C i  the presence of FeSO4Figur 6
Surface adhesion by A. baumannii SMAL clone grown 
in M9Glu/sup medium at 30°C in the presence of 
FeSO4. Grey bars: untreated samples; black bars: samples 
treated with 1 Unit cellulase.
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comial infections [1]. Our results show that biofilm for-
mation by the A. baumannii SMAL clone, measured as
ability to adhere to polystyrene microtiter plates, is
strongly affected by growth conditions, being inhibited in
the rich, peptone-based, LB medium (Figure 2A). 1:4 dilu-
tion of the LB medium was enough to stimulate surface
adhesion, which, however, was further increased by
growth in glucose-based medium (Figure 2A). Biofilm
stimulation by growth on glucose was also observed for
strains RUH875 and RUH134, representative of epidemic
European clones I and II (data not shown), in line with
similar effects reported for the A. baumannii strain ATCC
19606 [17]. These observations strongly suggest that, to
fully evaluate biofilm proficiency of A. baumannii clinical
isolates, biofilm assays should be carried out, not only in
peptone-based media, as reported in various studies [12-
14], but also in glucose-based media. Binding to the fluo-
rescent dye Calcofluor (Figure 2B) and biofilm sensitivity
to cellulase (Figure 2C) strongly suggest that growth on
glucose-based medium triggers production of cellulose, or
possibly of an EPS containing a β-1,4-glucan portion. Ini-
tial attempts to identify the chemical nature of the EPS
produced by A. baumannii SMAL would indeed suggest
that its composition is very complex (data not shown).
Production of a Calcofluor-binding EPS was not stimu-
lated by sugars other than glucose, such as sucrose (Figure
2B), as well as lactose and arabinose (data not shown),
thus suggesting that glucose is a specific inducer of EPS
production. Identification of a β-1,4-glucan-containing
EPS as an adhesion factor, and of its dependence on glu-
cose, is relevant for the understanding of which biofilm
determinants are produced by A. baumannii in different
environments and in different body sites during host col-
onization. Indeed, glucose concentration in blood, but
not in other A. baumannii infection sites such as in the uri-
nary tract, are similar to the concentrations used in our
experiments and would thus be able to induce EPS pro-
duction. In addition to promoting cell adhesion, produc-
tion of cellulose might contribute to protection from
macrophage killing, a role proposed for other bacterial
EPS such as alginate in P. aeruginosa [38]. We have identi-
fied putative glycosyltransferase-encoding genes in the A.
baumannii SMAL genome that might be involved in EPS
biosynthesis. However, attempts to inactivate genes possi-
bly involved in EPS biosynthesis and to assess their role
have not been successful so far.
Although A. baumannii SMAL clone is sensitive to imi-
penem in vitro (Table 1), treatments with this antibiotic
often failed to clear the patients from infections (data not
shown), thus suggesting that A. baumannii SMAL might
show tolerance to imipenem during host infection. We
investigated the possibility that A. baumannii SMAL sensi-
tivity to imipenem might be affected by different growth
conditions and/or by biofilm formation. MIC for imi-
penem in glucose-based medium was lower compared to
the MIC in peptone-based growth media (0.5 vs. 2 μg/ml;
data not shown), thus suggesting that biofilm formation
in M9Glu/sup does not result in increased resistance to
imipenem. However, exposure to subinhibitory imi-
penem concentrations (0.03-0.125 μg/ml) results in a 3-
fold stimulation of surface adhesion (Figure 4). Interest-
ingly, imipenem-dependent biofilm stimulation appears
to be distinctive for A. baumannii SMAL, since it was not
observed in strains RUH875 and RUH134, representative
of epidemic European clones I and II. It is likely that this
specific response to imipenem might contribute to A. bau-
mannii SMAL pathogenic and epidemic potential.
In addition, exposure to subinhibitory imipenem concen-
trations increased production of ferrichrome receptor pro-
tein and of TonB-like siderophore receptor protein, both
involved in iron uptake (Figure 5, Table 2). Imipenem-
dependent increase in expression of iron uptake proteins
is probably part of a more general response to a cellular
stress, rather than being induced by an actual reduction in
available iron by imipenem at the concentrations tested.
Iron uptake proteins play a key role during host infection
by various bacteria [39]; consistent with this function,
pathogenic A. baumannii strains possess a large number of
iron uptake genes in comparison to environmental iso-
lates [40]. Induction of ferrichrome receptor and the
TonB-like siderophore receptor proteins by imipenem
appears to take place via transcription activation of the
corresponding genes (Table 2). Thus, exposure to subin-
hibitory imipenem concentrations can trigger the produc-
tion of both biofilm determinants and iron uptake
proteins, in what appears to be a co-ordinated response to
cellular stresses. Direct connection between iron uptake
and biofilm formation is also suggested by the observa-
tion that increased FeSO4 concentrations in the growth
medium can act as a positive environmental signal for sur-
face adhesion in the A. baumannii SMAL clone (Figure 6).
Our results suggest that neither cellulose nor csu pili are
responsible for iron-dependent increase in surface adhe-
sion: interestingly, a recent report shows that adherence to
human airway epithelial cell is independent of csu pili
[41], thus suggesting that important adhesion and viru-
lence factors of A. baumannii are yet to be identified.
Conclusions
In the present study we have characterized a novel multi-
drug-resistant, pathogenic strain of A. baumannii (A. bau-
mannii SMAL clone). We have highlighted the importance
of environmental signals such as glucose and iron availa-
bility for biofilm formation by this strain. Our results sug-
gest that exposure to subinhibitory imipenem
concentrations stimulates iron uptake, which in turn leads
to an increased production of adhesion factors and bio-Page 10 of 14
(page number not for citation purposes)
BMC Microbiology 2009, 9:270 http://www.biomedcentral.com/1471-2180/9/270film formation. Induction of biofilm formation by subin-
hibitory antibiotic concentration, even when it does not
directly result in increased antibiotic resistance in vitro,
can nonetheless protect bacteria against killing by antimi-
crobials during host infection [33,42]. Understanding of
the molecular mechanism of imipenem-induced biofilm
formation could provide useful information for the
design of more effective protocols in antimicrobial ther-
apy.
Methods
Bacterial identification
A total of 69 A. baumannii non-replicated isolates, recov-
ered between 2002 and 2007 from patients in medical,
surgical and long-term care wards, were included in the
study. Isolates were collected in two different hospitals in
Pavia, Italy: the "I.R.C.C.S. Fondazione S. Maugeri", a Long-
Term Care Facility, and the "I.R.C.C.S. Fondazione S. Mat-
teo", an Acute Care Hospital. The isolates were initially
identified using the automatic systems Vitek 2
(BioMérieux, Marcy-l'Etoile, France) and Phoenix (Becton
Dickinson, Sparks, MD). Detection of blaOXA-51-like alleles
by PCR was used to confirm the identification of the iso-
lates as A. baumannii [43]. Antibiotic susceptibility was
determined using Phoenix System, Panel NMIC/ID4 (Bec-
ton Dickinson Diagnostic Systems). Carbapenems suscep-
tibility was confirmed by broth macrodilution procedures
according to CLSI guidelines (CLSI document M100-S18).
Escherichia coli ATCC 25922 and Pseudomonas aeruginosa
ATCC 27853 were used as reference quality control strains
of in vitro susceptibility tests. An isolate was defined as
multidrug resistant if resistant to at least three classes of
antibiotics commonly used in the treatment of A. bauman-
nii infections.
Characterization of -lactamases
Analytical isoelectric focusing (IEF) of crude extracts, vis-
ualization of β-lactamase bands by nitrocefin, and detec-
tion of their activity by a substrate overlaying procedure
were performed as described [44]. Known producers of
various β-lactamases (TEM-1, TEM-2, TEM-7, TEM-8,
TEM-9, TEM-12, SHV-1, SHV-2 and SHV-5) were used as
controls. PCR amplification of blaOXA-51 and of blaOXA-10-
like alleles was carried out with primers OXA-51-F (5'-
CTCTTACTTATMACAAGCGC-3') and OXA-51-R (5'-
CGAACAGAGCTAGRTATTC-3') (for blaOXA-51) and with
primers OXA-10-F (5'-GTCTTTCGAGTACGGCATTA-3')
and OXA-10-R (5'-ATTTTCTTAGCGGCAACTTAC-3') for
blaOXA-10-like [45]. The PCR amplicons of blaOXA-51 and
blaOXA-10 genes were purified using the kit Quantum Prep
PCR Kleen Spin Columns (BioRad) and subjected to
direct sequencing. PCR products were sequenced on both
strands with an Applied Biosystems sequencer. The nucle-
otide sequences were analysed with the BLAST program.
Genotyping of A. baumannii isolates
Genetic relatedness among A. baumanni isolates was
investigated by pulsed-field gel electrophoresis (PFGE):
genomic DNA was digested with ApaI restriction enzyme
and restricted fragments were separated on a CHEF-DR II
apparatus (Bio-Rad) for 20 h at 14°C. Bacteriophage λ
concatemers were used as DNA size markers. DNA restric-
tion patterns of scanned gel pictures were interpreted fol-
lowing cluster analysis with Fingerprinting II version 3.0
software (Bio-Rad) using the unweighted pair-group
method with arithmetic averages (UPGMA). The Dice cor-
relation coefficient was used with a 1.2% position toler-
ance to analyse the similarities of the banding patterns.
Only bands larger than 48 Kb were considered for the
analysis. Isolates showing more than three DNA fragment
differences and a similarity of <80% were considered to
represent different PFGE types, while isolates with less
than three fragment differences and a similarity of >80%
were considered as belonging to the same PFGE subtype,
following the criteria for genetic characterization using
PFGE described in the literature [23,46,47]. A. baumannii
RUH875 and RUH134 were used as reference strains rep-
resentative of the European clonal lineages I and II,
respectively [20,48].
Biofilm formation assays and determination of EPS 
production
Biofilm formation in microtiter plates was determined as
described [49]. Bacterial cells were grown overnight in
microtiter plates (0.2 ml) either at 30°C or 37°C. Bacte-
rial growth in the liquid culture was determined by optical
density at 600 nm (OD600 nm) and the liquid culture was
removed. Microtiter plates were washed with 0.1 M phos-
phate buffer (pH 7.0), and the biofilm cells attached to
the microtiter plate wells were stained for 20 min with 1%
crystal violet (CV) in ethanol, washed, and dried. Crystal
violet staining was visually assessed and the microtiter
plates were scanned. For semi-quantitative determination
of biofilms, CV-stained cells were resuspended in either
0.2 ml of 70% ethanol. The absorbance at 600 nm (Abs600
nm) of the resuspended CV was determined and normal-
ized to the OD600 nm of the corresponding grown cell den-
sity: this value corresponds to the "adhesion units". To
test biofilm sensitivity to cellulase, bacterial cultures were
grown in the presence of cellulase from Trichoderma reesei
ATCC 26921 (5 mg/ml, 700 U/ml, Sigma). For detection
of cellulose production by binding to the fluorescent dye
Calcofluor (CF), bacteria were grown overnight in a
microtiter plate, and the cultures were spotted, using a
replicator, on solid media to which 0.005% Calcofluor
(for CF medium) was added after autoclaving. Bacteria
were grown for 18-20 h at 30°C; staining was better
detected after 24-48 h of additional incubation at 4°C.Page 11 of 14
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A. baumannii cultures (100 ml) were grown in defined M9
medium, supplemented with 0.02% peptone and 0.01%
yeast extract, to which 0.2% glucose was added as main
carbon source (M9Glu/sup, [27]). Cultures were grown at
30°C up to 0.1 OD600 nm prior to addition of 0.125 μg/ml
imipenem (1/4 the MIC). Both control and treated cul-
tures were harvested 3 hours after imipenem addition, at
an OD600 nm >1.0. Bacterial cells were harvested by centrif-
ugation at 4,000 × g for 10 min at 4°C and washed with 5
ml 0.1 M phosphate buffer pH 7.0 (PB). The pellet was
resuspended in 2 ml PB with addition of 100 μg/ml lys-
ozyme and 1 mM EDTA pH 8.0 and incubated at room
temperature for 10 minutes. Cells were disintegrated
using a French Press and centrifuged as above to remove
unbroken cells. The low-speed centrifugation supernatant
was then centrifuged at 30,000 × g for 30 minutes at 4°C
to separate the cytoplasm (supernatant) and the mem-
brane fraction (pellet). The pellet was resuspended in 1 ml
of PB. Protein concentrations were determined and 25 μg
of total proteins was loaded onto a 10% sodium dodecyl
sulfate-polyacrylamide gel (SDS-PAGE). Bands of interest
were excised from the gel and the corresponding proteins
were identified by matrix-assisted laser desorption ioniza-
tion-time of flight (MALDI-TOF) analysis of the peptide
generated by in-gel trypsin digestion ([35]; performed by
CEINGE, University of Naples, Italy http://
www.ceinge.unina.it/).
Measurement of gene expression by Real Time-PCR
Gene expression determination was performed using Real
Time-PCR as previously described [29]. RNA was extracted
from bacterial cultures grown as for membrane protein
extraction. Production of cDNAs was obtained by reverse
transcription using 1 μg total RNA, along with negative
control samples incubated without reverse transcriptase.
Primer sequences for genes of interest were designed
based on the available genome sequences for A. baumannii
and were tested in PCR experiments on A. baumannii
SMAL genomic DNA to verify the presence of the gene and
the correctness of the expected products. Primer
sequences were as follows: fchR_for: 5'-ACGTCAAGCG-
GTTGCTCCAT-3', fchR_rev: 5'-CCTGTAATCGGGTCT-
GTTGG-3', tonB_for: 5'-ATGGCAAGATACCGATGCCC-
3', tonB_rev: 5'-CCGATATCTTCGCTTGAGCG-3',
csuC_for: 5'-GCCCGCCTGTAGCCAAAATT-3', csuC_rev:
5'-GAAGCATCTTGCTCGTTGCC-3', csuE_for: 5'-TAGCG-
GGCCTGATGGCAATT-3', csuE_rev: 5'-ACCCAG-
GGCTCTCAAAGAAG-3', 16S_for: 5'-
TGTCGTCAGCTCGTGTCGTGA-3', 16S_rev: 5'-TGAT-
GACTTGACGTCGTCCCC-3'. Each Real Time PCR experi-
ment was performed in triplicate and included negative
control samples, which never showed significant thresh-
old cycles. The relative transcript amounts were deter-
mined using 16S rRNA as the reference gene ([CtGene of
interest-Ct16S] = ΔCt value). The results are the average of at
least three independent experiments showing standard
deviations ≤10%.
Other methods
Resistance to desiccation was performed as described in
[29]. Sensitivity to oxidative stress was determined by
treatment with hydrogen peroxide (H2O2), as described
previously [50]. Transmission electron microscopy analy-
sis was performed as described [51].
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